About

About Parimer Scientific Drug Development Parimer collaborates with emerging biotechnology companies in their early-stage development and clinical trial manufacturing. Parimer has supported over 25 similar companies in the last several years to bring their biotechnology to the commercial market. Parimer is compliant with ICHQ7 standards, licensed, and accredited for cGMP manufacturing for human use. About Parimer Scientific Drug Development Parimer collaborates with emerging biotechnology companies in their early-stage development and clinical trial manufacturing. Parimer has supported over 25 similar companies in the last several years to bring their biotechnology to the commercial market. Parimer is compliant with ICHQ7 standards, licensed, and accredited for cGMP manufacturing for human use. Parimer Scientific: Precision Chemistry, Relentless Execution Parimer Scientific is a privately held contract development and manufacturing organization (CDMO) based in South Carolina, USA. We specialize in helping life science innovators bring complex products to market with speed, precision, and regulatory confidence. Our team is intentionally small—lean, focused, and deeply invested in the success of every project we take on. We are not a traditional CDMO. We are a hands-on, execution-first partner that integrates directly into your development pipeline. Our scientists and engineers work shoulder-to-shoulder with clients, taking ownership of outcomes and delivering results with urgency and pride. With minimal executive overhead and no layers of bureaucracy, we move fast, communicate clearly, and stay accountable from kickoff to commercialization. We also navigate the regulatory landscape with confidence, maintaining ISO, USP, and FDA compliance through rigorous audits and certifications. Over the past decade, Parimer has supported the successful commercialization of more than a dozen biotech innovations. Our clients range from early-stage startups to multinational pharmaceutical companies, and our work spans APIs, medical devices, biologics, and specialty chemicals. Whether you need a kilo of GMP material, a regulatory-ready CMC package, or a custom polymer for a combination product, we deliver with rigor and reliability. Parimer’s core strength lies in chemistry. Our team of PhD- and MS-level chemists brings deep expertise in synthetic organic chemistry, analytical chemistry, and chemical engineering. We support projects from milligram-scale R&D to kilo-scale GMP manufacturing, with a focus on speed, flexibility, and compliance. We develop and scale active pharmaceutical ingredients (APIs) for clinical and commercial use, including CNS-active agents, transdermal compounds, deuterated analogs of active compounds, and controlled substances under DEA Schedule I–V. In the medical device space, we formulate and manufacture polymeric components and excipients for Class I and II devices, including bioresorbable polymers, custom polymeric excipients for drug-device combination products, and hydrogels and elastomers for implantable systems. Our biologics and complex molecule capabilities include the development and manufacturing of polysaccharides such as USP-grade chitosan, adjuvants for vaccine formulations, and recombinant proteins, peptides, and oligonucleotides. We also serve adjacent industries with specialty and agricultural chemical projects, including extraction and purification from marine biomass and analytical method development for agrochemical compounds. Parimer excels in custom chemistry and route development. We routinely perform reverse engineering, route scouting, and purification of complex mixtures, and we specialize in developing scalable synthetic routes for rare or unstable intermediates. Our in-house analytical suite includes HPLC, GC, FTIR, GPC, UV-Vis, DSC, ICP-MS, ROI, and LOD, along with microbial and bioscreening assays. For advanced techniques such as NMR, SEM, XRD, and XRF, we collaborate with trusted local partners. To further enhance our capabilities, Parimer integrates artificial intelligence into our workflows. Predictive modeling tools help us optimize synthetic routes, forecast stability profiles, and identify potential impurities before they arise. These tools empower our scientists to focus on high-value problem-solving and innovation. Our ISO-accredited, GMP-compliant cleanroom facility is licensed by the DEA and FDA to handle all schedules of drug classifications. We are NSF-accredited under ISO 9001 and audited annually to ensure the highest standards of quality and compliance. Designed for flexibility, our facility allows us to pivot quickly between projects while maintaining rigorous documentation and traceability. We maintain a 95%+ on-time delivery rate and are committed to transparency, precision, and continuous improvement. Our project managers are incentivized to deliver under budget and ahead of schedule, and our quality systems are built to scale with your needs. We understand that our clients entrust us with their most sensitive intellectual property. Confidentiality is not just a policy—it’s a pillar of our culture. All projects are governed by strict NDAs, and our facility is designed with secure data handling protocols, restricted access zones, and audit-ready documentation systems. We have never had a breach of client confidentiality, and we intend to keep it that way. At Parimer, we don’t just complete tasks—we take ownership. Every member of our team is empowered to make decisions, solve problems, and drive projects forward. We are passionate about science, obsessed with quality, and relentless in our pursuit of results. Our size is our strength. We are nimble, responsive, and personally invested in every project we take on. We don’t hide behind process—we lead with purpose.